Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.3% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
36
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.9% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
14 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
43.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Poste Italiane
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
E-commerce And Digital Payments Will Secure A Robust Market Future
Key Takeaways Expansion in e-commerce logistics and digital delivery is driving market share gains and supporting future revenue and margin growth amid declining mail volumes. Digital payments, insurance, and omnichannel strategies are boosting profitability, recurring fee income, and customer retention, enhancing long-term earnings resilience.
View narrative
€19.35
FV
5.6% overvalued
intrinsic discount
0.51%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
20
users have followed this narrative
5 days ago
author updated this narrative
Amphenol
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Global Supply Chain Woes Will Shrink Margins And Raise Costs
Key Takeaways Emerging technologies and heightened competition risk eroding Amphenol's margins, pricing power, and sales growth across core legacy products. Regulatory, supply chain, and R&D pressures are expected to increase costs, straining profitability and free cash flow in the face of uncertain returns.
View narrative
US$90.62
FV
21.0% overvalued
intrinsic discount
12.13%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
ZTO Express (Cayman)
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
China's E-Commerce And Automation Will Secure Resilient Market Leadership
Key Takeaways Rapid adoption of automation, AI, and premium service offerings is driving cost reductions, margin expansion, and earnings stability. Stabilizing industry pricing and improved parcel mix support sustained revenue growth and enhance ZTO's competitive market position.
View narrative
US$22.95
FV
17.5% undervalued
intrinsic discount
11.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
5 days ago
author updated this narrative
Harmony Biosciences Holdings
AN
AnalystHighTarget
Consensus Narrative from 11 Analysts
Aging Populations And WAKIX Trials Will Expand Rare Disease Treatment
Key Takeaways Robust WAKIX growth and expansion into new indications position Harmony for sustained, outsized revenue and margin gains beyond market expectations. Strong cash reserves and business development set up Harmony as a leading consolidator and innovator in rare neurological diseases and regenerative therapies.
View narrative
US$70.00
FV
46.5% undervalued
intrinsic discount
20.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Trane Technologies
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Legacy HVAC Demand Will Decline Under Rising Regulatory Pressure
Key Takeaways Accelerating adoption of advanced, energy-efficient technologies and rising regulations threaten Trane's traditional HVAC revenue, raising risk of market share erosion and higher compliance costs. Heavy reliance on North American commercial HVAC and vulnerability to global trade disruptions expose Trane to topline stagnation, margin compression, and increased competition from innovative rivals.
View narrative
US$344.71
FV
21.8% overvalued
intrinsic discount
6.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Progyny
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Delayed Parenthood And Healthcare Consumerism Will Boost Fertility Ecosystem
Key Takeaways Expanding partnerships and platform innovations are driving stronger insurer adoption, enhancing utilization and pricing power, and positioning the company as essential for employer-offered fertility benefits. Strategic alliances, robust cash flow, and rising demand from younger employees enable brand leadership, accelerating organic growth and offering high optionality for future expansion.
View narrative
US$32.00
FV
27.7% undervalued
intrinsic discount
12.67%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Fidelis Insurance Holdings
AN
AnalystHighTarget
Consensus Narrative from 9 Analysts
Global Wealth And Catastrophe Demands Will Drive Specialty Insurance
Key Takeaways Accelerated partner onboarding, advanced analytics, and industry digitalization are set to drive outsized revenue growth, market share gains, and sustainable profitability improvements. Flexible capital markets strategies and specialization in complex insurance lines position Fidelis for higher margins and earnings resilience amid rising global risk and ESG demands.
View narrative
US$26.43
FV
35.2% undervalued
intrinsic discount
11.80%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Ziff Davis
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Digital Advertising And Data Privacy Will Drive Secular Momentum
Key Takeaways Enhanced AI-driven data monetization and granular segment disclosures are boosting investor confidence and unlocking higher valuation potential across diverse, profitable business verticals. Strategic global expansion and targeted acquisitions are accelerating recurring revenue streams, strengthening Ziff Davis's position in high-growth, high-margin technology and subscription markets.
View narrative
US$59.09
FV
35.9% undervalued
intrinsic discount
4.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Tronox Holdings
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Global Urbanization And Sustainability Trends Will Boost Titanium Dioxide Markets
Key Takeaways Accelerated cost-saving efforts and operational optimizations are set to boost margins and earnings ahead of initial expectations as market conditions recover. Expansion into rare earth minerals and strengthened mining capacity position Tronox for long-term growth and increased pricing power beyond traditional markets.
View narrative
US$7.00
FV
39.3% undervalued
intrinsic discount
3.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies